{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:34:49Z","timestamp":1785454489229,"version":"3.56.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T00:00:00Z","timestamp":1366761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives.<\/jats:title>\n                  <jats:p>Two cases of adenoid cystic carcinoma (ACC) of the larynx were treated with chemoradiotherapy (CRT) for organ preservation. We reviewed case series and current literature to contrast the potential role of primary CRT as an organ-sparing modality with standard laryngectomy and radiotherapy in patients with laryngeal ACC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods.<\/jats:title>\n                  <jats:p>Two treatment-na\u00efve patients with laryngeal ACC treated at Dana-Farber Cancer Institute between 2002 and 2007 were identified. Both patients were offered standard laryngectomy followed by adjuvant radiotherapy or organ-sparing treatment modality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results.<\/jats:title>\n                  <jats:p>Both patients were males, aged 57 and 73. The patients completed a course of combined chemoradiotherapy with weekly carboplatin and paclitaxel and 7\u20138 weeks of radiotherapy to a total dose of 6,600 and 7,000 cGy over 50 and 57 days, respectively. There were no treatment breaks or delays because of toxicity. The major toxicities reported by both patients, as anticipated, were Grade 3 mucositis, desquamative dermatitis, and severe dysphagia, all of which resolved. Both patients are alive with local regional control and functional larynx; one at 112+ months with pulmonary metastases at 54 months, and the other disease free at 60+ months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions.<\/jats:title>\n                  <jats:p>Definitive chemoradiation with weekly carboplatin and paclitaxel may be a potential alternative to the current standard of surgery and radiation for patients with locally advanced laryngeal ACC who request an organ-sparing approach. In this group of patients, salvage laryngectomy may be reserved for those who are locally recurrent or chemoradiotherapy resistant. Although CRT provided long-term local regional control in our two patients, there are evident limitations in obtaining evidence for a determination of treatment of rare diseases. This report provides support for following an organ preservation plan in selected patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1634\/theoncologist.2012-0349","type":"journal-article","created":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T01:02:49Z","timestamp":1366851769000},"page":"579-583","source":"Crossref","is-referenced-by-count":18,"title":["Organ Preservation for Adenoid Cystic Carcinoma of the Larynx"],"prefix":"10.1093","volume":"18","author":[{"given":"Krzysztof J.","family":"Misiukiewicz","sequence":"first","affiliation":[{"name":"Department of Medicine, Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Camille","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Tishler","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Haddad","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sewanti","family":"Limaye","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Posner","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,4,24]]},"reference":[{"key":"2021122308345752500_B1","volume-title":"Statistical basis: This is based on an incidence rate of 0.4 per 100,000 (Source: SEER) and a population of 305.8 million (Source: U.S. Census Bureau)"},{"key":"2021122308345752500_B2","volume-title":"Statistical basis: This is based upon the prevalence rate of 1.49 per 100,000 (Source: SEER)"},{"key":"2021122308345752500_B3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1054\/ijom.2003.0448","article-title":"Adenoid cystic carcinoma of the head and neck\u2014A 20 years experience","volume":"33","author":"Kokemueller","year":"2004","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2021122308345752500_B4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.oraloncology.2005.06.024","article-title":"Prognostic factors in head and neck adenoid cystic carcinoma","volume":"42","author":"Cruz Perez","year":"2006","journal-title":"Oral Oncol"},{"key":"2021122308345752500_B5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/archotol.125.2.149","article-title":"Adenoid cystic carcinoma of the head and neck: Predictors of morbidity and mortality","volume":"125","author":"Cruz Perez","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2021122308345752500_B6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ijc.1013","article-title":"Adenoid cystic carcinoma: A retrospective clinical review","volume":"96","author":"Khan","year":"2001","journal-title":"Int J Cancer"},{"key":"2021122308345752500_B7","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1177\/000348949210101212","article-title":"Nonsquamous carcinomas of the larynx","volume":"101","author":"Batsakis","year":"1992","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2021122308345752500_B8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/000348949910800512","article-title":"Glandular carcinoma of the larynx: The UCLA experience","volume":"108","author":"Alavi","year":"1999","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2021122308345752500_B9","first-page":"244","article-title":"Cystic adenoid carcinoma of the larynx: Two cases","volume":"120","author":"Dexemple","year":"2003","journal-title":"Ann Otolaryngol Chir Cervicofac"},{"key":"2021122308345752500_B10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hed.10380","article-title":"Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck","volume":"26","author":"Mendenhall","year":"2004","journal-title":"Head Neck"},{"key":"2021122308345752500_B11","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1200\/JCO.2005.05.3025","article-title":"Systemic therapy in the palliative management of advanced salivary gland cancers","volume":"24","author":"Laurie","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021122308345752500_B12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.coc.0000203756.36866.17","article-title":"Chemoradiotherapy for adenoid cystic carcinoma: Preliminary results of an organ sparing approach","volume":"29","author":"Haddad","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"2021122308345752500_B13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10147-006-0587-0","article-title":"Salivary gland carcinoma treated with concomitant chemoradiation with intraarterial cisplatin and docetaxel","volume":"11","author":"Maruya","year":"2006","journal-title":"Int J Clin Oncol"},{"key":"2021122308345752500_B14","first-page":"272","article-title":"Unresectable adenoid cystic carcinoma of the trachea treated with chemoradiotherapy","volume":"12","author":"Sasiaja","year":"2000","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2021122308345752500_B15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ajo.2005.08.068","article-title":"Clinical analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma","volume":"141","author":"Tse","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"2021122308345752500_B16","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"2021122308345752500_B17","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"2021122308345752500_B18","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","article-title":"Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group","volume":"88","author":"Lefebvre","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"2021122308345752500_B19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer","volume":"324","author":"The Department of Veterans Affairs Laryngeal Cancer Study Group","year":"1991","journal-title":"N Engl J Med"},{"key":"2021122308345752500_B20","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1200\/JCO.2006.07.4559","article-title":"American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer","volume":"24","author":"Pfister","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021122308345752500_B21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archotol.129.1.44","article-title":"Outcome of salvage total laryngectomy following organ preservation therapy: The Radiation Therapy Oncology Group trial 91\u201311","volume":"129","author":"Weber","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2021122308345752500_B22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1470-2045(10)70245-X","article-title":"Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: A systematic review","volume":"12","author":"Laurie","year":"2011","journal-title":"Lancet Oncol"},{"key":"2021122308345752500_B23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0360-3016(92)90888-O","article-title":"Taxol: A novel radiation sensitizer","volume":"22","author":"Tishler","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122308345752500_B24","first-page":"3506","article-title":"Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel","volume":"54","author":"Milas","year":"1994","journal-title":"Cancer Res"},{"key":"2021122308345752500_B25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/hed.20802","article-title":"Adenoid cystic carcinoma of the larynx: A 40-year experience","volume":"30","author":"Moukarbel","year":"2008","journal-title":"Head Neck"},{"key":"2021122308345752500_B26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9610(85)90166-7","article-title":"Cancer of the minor salivary glands of the larynx","volume":"150","author":"Cohen","year":"1985","journal-title":"Am J Surg"},{"key":"2021122308345752500_B27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.amjoto.2011.07.003","article-title":"Adenoid cystic carcinoma of the airway: A 30-year review at one institution","volume":"33","author":"Calzada","year":"2012","journal-title":"Am J Otolaryngol"},{"key":"2021122308345752500_B28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10637-008-9128-1","article-title":"Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinoma","volume":"26","author":"Carter","year":"2008","journal-title":"Invest New Drugs"},{"key":"2021122308345752500_B29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0360-3016(00)00408-9","article-title":"The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck","volume":"47","author":"Suntharalingam","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122308345752500_B30","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1002\/cncr.24525","article-title":"Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin\/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer","volume":"115","author":"Haddad","year":"2009","journal-title":"Cancer"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2012-0349","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2012-0349","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/18\/5\/579\/41856747\/oncolo_18_5_579.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/18\/5\/579\/41856747\/oncolo_18_5_579.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:48:10Z","timestamp":1640306890000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/18\/5\/579\/6410218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,24]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,4,24]]},"published-print":{"date-parts":[[2013,5,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2012-0349","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,5,1]]},"published":{"date-parts":[[2013,4,24]]}}}